aTYR PHARMA INC
ATYRNasdaqCIK 1339970HealthcareFiscal year ends Dec 31
Reports and events: 219 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2709:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001339970-26-000071 |
| 2026-10-1616:02 ET | 8-K | 5.07 Shareholder vote results | 0001339970-26-000068 |
| 2026-09-2407:47 ET | 8-K | 8.01 Other events | 0001339970-26-000065 |
| 2026-09-1116:06 ET | DEF 14A | Proxy statementPeriod 2026-10-16 | 0001339970-26-000061 |
| 2026-08-0716:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001339970-26-000053 |
| 2026-08-0716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001339970-26-000051 |
| 2026-07-3116:44 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001339970-26-000042 |
| 2026-06-0816:04 ET | 8-K | 3.01 Delisting notice | 0001339970-26-000039 |
| 2026-06-0116:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001339970-26-000036 |
| 2026-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001339970-26-000033 |
| 2026-05-1508:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001339970-26-000030 |
| 2026-05-1116:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001339970-26-000027 |
| 2026-03-2616:08 ET | DEF 14A | Proxy statementPeriod 2026-03-26 | 0001339970-26-000021 |
| 2026-03-0516:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001339970-26-000008 |
| 2026-03-0516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001339970-26-000006 |
| 2025-12-0516:05 ET | 8-K | 3.01 Delisting notice | 0001193125-25-309619 |
| 2025-11-0616:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269587 |
| 2025-11-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269486 |
| 2025-09-1508:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-202865 |
| 2025-08-0821:33 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001339970-25-000016 |
| 2025-08-0716:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001339970-25-000009 |
| 2025-08-0716:03 ET | 8-K | 2.06 Material impairments; 9.01 Financial statements and exhibits | 0001339970-25-000007 |
| 2025-05-0716:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065640 |
| 2025-05-0716:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065611 |
| 2025-05-0616:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-064413 |
| 2025-03-1916:08 ET | DEF 14A | Proxy statementPeriod 2025-03-19 | 0000950170-25-041992 |
| 2025-03-1317:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-038888 |
| 2025-03-1316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-038703 |
| 2024-12-2316:42 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-139633 |
| 2024-12-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-135766 |
| 2024-11-0716:07 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123305 |
| 2024-11-0716:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123256 |
| 2024-08-1316:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096185 |
| 2024-08-1316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096139 |
| 2024-07-2208:30 ET | 8-K | 8.01 Other events | 0000950170-24-085058 |
| 2024-05-2916:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.05 Item not in the standard list; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-065899 |
| 2024-05-0216:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052092 |
| 2024-05-0216:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-052058 |
| 2024-04-0516:00 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0000950170-24-042236 |
| 2024-03-1416:38 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-031584 |
| 2024-03-1416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-031441 |
| 2023-11-0916:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062058 |
| 2023-11-0916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062020 |
| 2023-09-2609:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-049802 |
| 2023-09-1108:04 ET | 8-K | 8.01 Other events | 0000950170-23-047360 |
| 2023-08-0916:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040598 |
| 2023-08-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040581 |
| 2023-05-1916:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-023257 |
| 2023-05-0916:14 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019686 |
| 2023-05-0916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-019633 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 09:04 ET. Listed shows no prices and gives no investment advice.